Terms: = Colorectal cancer AND KRAS, C-K-RAS, 3845, P01116, NS3, KI-RAS, KRAS2, K-RAS4A, K-RAS2A, K-RAS4B, KRAS1, K-RAS2B, RASK2 AND Prognosis
993 results:
1. Genomic Alterations and Clinical Characterization in Chinese Patients with Metastatic colorectal cancer.
Zhang XH; Zhou JQ; Wei Q; Li J; Xu T; Bai CM; Zhou JF; Wang XC
Discov Med; 2024 Jul; 36(186):1477-1485. PubMed ID: 39054718
[TBL] [Abstract] [Full Text] [Related]
2. Targeted panel sequencing of pharmacogenes and oncodrivers in colorectal cancer patients reveals genes with prognostic significance.
Heczko L; Liška V; Vyčítal O; Fiala O; Šůsová S; Hlaváč V; Souček P
Hum Genomics; 2024 Jul; 18(1):83. PubMed ID: 39030589
[TBL] [Abstract] [Full Text] [Related]
3. Identification and validation of calcium extrusion-related genes prognostic signature in colon adenocarcinoma.
Jin M; Yin C; Yang J; Yang X; Wang J; Zhu J; Yuan J
PeerJ; 2024; 12():e17582. PubMed ID: 39006025
[TBL] [Abstract] [Full Text] [Related]
4. Epidermal Growth Factor Receptor Targeting in colorectal Carcinoma: Antibodies and Patient-Derived Organoids as a Smart Model to Study Therapy Resistance.
Tardito S; Matis S; Zocchi MR; Benelli R; Poggi A
Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000238
[TBL] [Abstract] [Full Text] [Related]
5. Novel drug resistance mechanisms and drug targets in BRAF-mutated peritoneal metastasis from colorectal cancer.
Lund-Andersen C; Torgunrud A; Kanduri C; Dagenborg VJ; Frøysnes IS; Larsen MM; Davidson B; Larsen SG; Flatmark K
J Transl Med; 2024 Jul; 22(1):646. PubMed ID: 38982444
[TBL] [Abstract] [Full Text] [Related]
6. Multifaceted effects of LRP6 in cancer: exploring tumor development, immune modulation and targeted therapies.
Li L; Zhao L; Yang J; Zhou L
Med Oncol; 2024 Jun; 41(7):180. PubMed ID: 38898247
[TBL] [Abstract] [Full Text] [Related]
7. To explore the prognostic characteristics of colon cancer based on tertiary lymphoid structure-related genes and reveal the characteristics of tumor microenvironment and drug prediction.
Wang Z; Niu D
Sci Rep; 2024 Jun; 14(1):13555. PubMed ID: 38867070
[TBL] [Abstract] [Full Text] [Related]
8. MYG1 drives glycolysis and colorectal cancer development through nuclear-mitochondrial collaboration.
Chen J; Duan S; Wang Y; Ling Y; Hou X; Zhang S; Liu X; Long X; Lan J; Zhou M; Xu H; Zheng H; Zhou J
Nat Commun; 2024 Jun; 15(1):4969. PubMed ID: 38862489
[TBL] [Abstract] [Full Text] [Related]
9. Unlocking the potential of flavonoids: Natural solutions in the fight against colon cancer.
Hasibuan PAZ; Simanjuntak Y; Hey-Hawkins E; Lubis MF; Rohani AS; Park MN; Kim B; Syahputra RA
Biomed Pharmacother; 2024 Jul; 176():116827. PubMed ID: 38850646
[TBL] [Abstract] [Full Text] [Related]
10. [Incidence of common gene mutations in early-onset colorectal cancer and the association with cancer survival: a meta-analysis].
Zhang RQ; Li SH; Hu TJ; Xu LY; Zhu YS; Li X
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 May; 27(5):495-506. PubMed ID: 38778689
[TBL] [Abstract] [Full Text] [Related]
11. colorectal cancer subtyping and immune landscape analysis based on natural killer cell-related genes.
Ding M; Gao J; Wang J; Li Z; Gong X; Cui Z; Li C; Xue H; Li D; Wang Y
Arab J Gastroenterol; 2024 May; 25(2):150-159. PubMed ID: 38719664
[TBL] [Abstract] [Full Text] [Related]
12. Use of Deep Learning to Evaluate Tumor Microenvironmental Features for Prediction of Colon cancer Recurrence.
Sinicrope FA; Nelson GD; Saberzadeh-Ardestani B; Segovia DI; Graham RP; Wu C; Hagen CE; Shivji S; Savage P; Buchanan DD; Jenkins MA; Phipps AI; Swallow C; LeMarchand L; Gallinger S; Grant RC; Pai RK; Sinicrope SN; Yan D; Shanmugam K; Conner J; Cyr DP; Kirsch R; Banerjee I; Alberts SR; Shi Q; Pai RK
Cancer Res Commun; 2024 May; 4(5):1344-1350. PubMed ID: 38709069
[TBL] [Abstract] [Full Text] [Related]
13. Construction and validation of "WCH-nomogram" for predicting the prognosis after resection of colorectal liver metastases.
Jiang C; Liu W; Jin Z; Lan L; Xu L; Du A; Peng S; Zeng Y; Wang H; Liao M; Zhou J
Cancer Med; 2024 May; 13(9):e7222. PubMed ID: 38698687
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic value of specific kras mutations in patients with colorectal peritoneal metastases.
Tonello M; Baratti D; Sammartino P; Di Giorgio A; Robella M; Sassaroli C; Framarini M; Valle M; Macrì A; Graziosi L; Coccolini F; Lippolis PV; Gelmini R; Deraco M; Biacchi D; Aulicino M; Vaira M; De Franciscis S; D'Acapito F; Carboni F; Milone E; Donini A; Fugazzola P; Faviana P; Sorrentino L; Pizzolato E; Cenzi C; Del Bianco P; Sommariva A
ESMO Open; 2024 Apr; 9(4):102976. PubMed ID: 38613907
[TBL] [Abstract] [Full Text] [Related]
15. Identification of a gene expression signature associated with brain metastasis in colorectal cancer.
Michl M; Taverna F; Woischke C; Li P; Klauschen F; Kirchner T; Heinemann V; von Bergwelt-Baildon M; Stahler A; Herold TM; Jurinovic V; Engel J; Kumbrink J; Neumann J
Clin Transl Oncol; 2024 Aug; 26(8):1886-1895. PubMed ID: 38558282
[TBL] [Abstract] [Full Text] [Related]
16. [colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
[No Abstract] [Full Text] [Related]
17. prognosis of a Heterogeneous TRG Pathological Response to Neoadjuvant Chemotherapy in Patients who Undergo Resection for colorectal Liver Metastases.
Laroche S; Scatton O; Charlotte F; Bachet JB; Lim C; Fuks D; Goumard C
Ann Surg Oncol; 2024 Jul; 31(7):4436-4444. PubMed ID: 38549003
[TBL] [Abstract] [Full Text] [Related]
18. Concurrent kras p.G12C mutation and ANK3::RET fusion in a patient with metastatic colorectal cancer: a case report.
Bedau T; Heydt C; Siebolts U; Zander T; Kraemer M; Loeser H; Buettner R; Quaas A
Diagn Pathol; 2024 Mar; 19(1):55. PubMed ID: 38539256
[TBL] [Abstract] [Full Text] [Related]
19. Impact of kras mutation on the tumor microenvironment in colorectal cancer.
Zhou Y; Kuang Y; Wang C; Yu Y; Pan L; Hu X
Int J Biol Sci; 2024; 20(5):1947-1964. PubMed ID: 38481800
[TBL] [Abstract] [Full Text] [Related]
20. Negative prognostic impact of Co-mutations in TGFβ and TP53 pathways in surgically resected rectal tumors following neoadjuvant chemoradiotherapy.
Qian C; Yang W; Li M; Feng Y; Dai N; Luo H; Jian D; Li X; Yang Y; He Y; Wang D; Li C; Xiao H
Eur J Surg Oncol; 2024 Apr; 50(4):108242. PubMed ID: 38460248
[TBL] [Abstract] [Full Text] [Related]
[Next]